Veeva Systems Inc. (NYSE:VEEV – Get Free Report) has earned an average recommendation of “Moderate Buy” from the twenty ratings firms that are currently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have assigned a buy rating to the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $234.90.
A number of research analysts recently issued reports on the company. Barclays boosted their price objective on Veeva Systems from $240.00 to $245.00 and gave the company an “overweight” rating in a research report on Friday, March 1st. JPMorgan Chase & Co. lifted their target price on Veeva Systems from $183.00 to $222.00 and gave the company a “neutral” rating in a research note on Wednesday, March 13th. Oppenheimer reaffirmed an “outperform” rating and set a $225.00 target price on shares of Veeva Systems in a research note on Thursday, February 22nd. Raymond James reaffirmed an “outperform” rating and set a $260.00 target price on shares of Veeva Systems in a research note on Tuesday, March 26th. Finally, Citigroup lifted their target price on Veeva Systems from $240.00 to $264.00 and gave the company a “buy” rating in a research note on Friday, March 1st.
Check Out Our Latest Research Report on Veeva Systems
Insiders Place Their Bets
Institutional Trading of Veeva Systems
A number of hedge funds and other institutional investors have recently modified their holdings of VEEV. Facet Wealth Inc. grew its stake in shares of Veeva Systems by 3.2% in the fourth quarter. Facet Wealth Inc. now owns 1,542 shares of the technology company’s stock worth $323,000 after purchasing an additional 48 shares during the last quarter. UMB Bank n.a. grew its stake in shares of Veeva Systems by 2.5% in the third quarter. UMB Bank n.a. now owns 2,103 shares of the technology company’s stock worth $428,000 after purchasing an additional 51 shares during the last quarter. NewEdge Wealth LLC grew its stake in shares of Veeva Systems by 0.6% in the third quarter. NewEdge Wealth LLC now owns 10,059 shares of the technology company’s stock worth $2,047,000 after purchasing an additional 60 shares during the last quarter. Yousif Capital Management LLC grew its stake in shares of Veeva Systems by 3.5% in the fourth quarter. Yousif Capital Management LLC now owns 1,777 shares of the technology company’s stock worth $342,000 after purchasing an additional 60 shares during the last quarter. Finally, Personal CFO Solutions LLC grew its stake in shares of Veeva Systems by 5.9% in the third quarter. Personal CFO Solutions LLC now owns 1,091 shares of the technology company’s stock worth $222,000 after purchasing an additional 61 shares during the last quarter. Institutional investors own 88.20% of the company’s stock.
Veeva Systems Stock Performance
Shares of VEEV opened at $198.37 on Friday. The company has a market capitalization of $32.00 billion, a P/E ratio of 61.61, a P/E/G ratio of 2.02 and a beta of 0.74. Veeva Systems has a one year low of $160.21 and a one year high of $236.90. The stock has a 50-day moving average price of $221.17 and a 200 day moving average price of $202.80.
Veeva Systems (NYSE:VEEV – Get Free Report) last issued its earnings results on Thursday, February 29th. The technology company reported $0.92 EPS for the quarter, topping the consensus estimate of $0.81 by $0.11. The company had revenue of $630.62 million during the quarter, compared to analyst estimates of $620.75 million. Veeva Systems had a return on equity of 11.26% and a net margin of 22.24%. As a group, equities research analysts forecast that Veeva Systems will post 4.11 earnings per share for the current fiscal year.
About Veeva Systems
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Further Reading
- Five stocks we like better than Veeva Systems
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Comprehensive Analysis of PayPal Stock
- What is a Low P/E Ratio and What Does it Tell Investors?
- Intuitive Surgical Stock Can Trend Much Higher This YearÂ
- How to Invest in Blue Chip Stocks
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.